Product NDC: | 0338-3993 |
Proprietary Name: | IFEX |
Non Proprietary Name: | ifosfamide |
Active Ingredient(s): | 3 g/1 & nbsp; ifosfamide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-3993 |
Labeler Name: | BAXTER HEALTHCARE CORPORATION |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019763 |
Marketing Category: | NDA |
Start Marketing Date: | 20120301 |
Package NDC: | 0338-3993-01 |
Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0338-3993-01) |
NDC Code | 0338-3993-01 |
Proprietary Name | IFEX |
Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0338-3993-01) |
Product NDC | 0338-3993 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ifosfamide |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120301 |
Marketing Category Name | NDA |
Labeler Name | BAXTER HEALTHCARE CORPORATION |
Substance Name | IFOSFAMIDE |
Strength Number | 3 |
Strength Unit | g/1 |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |